Company focused on manufacturing and commercialization in partnership with Zimmer Biomet
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it shipped the first commercial order to Zimmer Biomet for its Evo sEEG Electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. Zimmer Biomet is the exclusive worldwide distribution partner for the NeuroOne Evo Cortical and sEEG electrode product lines.
https://finance.yahoo.com/news/neuroone-ships-initial-zimmer-biomet-140000727.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.